Russell Investments Group, Ltd. Editas Medicine, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 51,161 shares of EDIT stock, worth $77,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,161
Previous 57,619 11.21%
Holding current value
$77,764
Previous $269,000 35.32%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$3.39 - $5.96 $21,892 - $38,489
-6,458 Reduced 11.21%
51,161 $174,000
Q2 2024

Aug 08, 2024
BUY
$4.67 - $7.28 $209,127 - $326,005
44,781 Added 348.82%
57,619 $269,000
Q1 2024

May 08, 2024
BUY
$7.03 - $11.07 $53,765 - $84,663
7,648 Added 147.36%
12,838 $95,000
Q4 2023

Feb 05, 2024
BUY
$6.25 - $11.11 $25,975 - $46,173
4,156 Added 401.93%
5,190 $52,000
Q3 2023

Nov 13, 2023
SELL
$6.92 - $9.31 $9,362 - $12,596
-1,353 Reduced 56.68%
1,034 $8,000
Q2 2023

Aug 10, 2023
SELL
$6.36 - $11.47 $597 - $1,078
-94 Reduced 3.79%
2,387 $19,000
Q1 2023

May 09, 2023
SELL
$7.03 - $11.53 $83,403 - $136,791
-11,864 Reduced 82.7%
2,481 $17,000
Q4 2022

Feb 08, 2023
SELL
$8.32 - $13.21 $199,288 - $316,419
-23,953 Reduced 62.54%
14,345 $127,000
Q3 2022

Nov 04, 2022
BUY
$12.16 - $19.42 $432,652 - $690,963
35,580 Added 1309.05%
38,298 $466,000
Q2 2022

Jul 29, 2022
BUY
$9.99 - $21.35 $27,152 - $58,029
2,718 New
2,718 $32,000
Q1 2022

May 05, 2022
SELL
$14.08 - $27.63 $248,188 - $487,034
-17,627 Closed
0 $0
Q4 2021

Jan 21, 2022
SELL
$26.55 - $40.57 $472,696 - $722,308
-17,804 Reduced 50.25%
17,627 $466,000
Q3 2021

Nov 08, 2021
BUY
$39.27 - $72.94 $534,621 - $993,005
13,614 Added 62.4%
35,431 $1.45 Million
Q2 2021

Aug 04, 2021
SELL
$31.29 - $56.64 $808,251 - $1.46 Million
-25,831 Reduced 54.21%
21,817 $1.23 Million
Q1 2021

May 10, 2021
SELL
$39.71 - $90.58 $360,884 - $823,191
-9,088 Reduced 16.02%
47,648 $2 Million
Q4 2020

Feb 08, 2021
SELL
$27.07 - $84.35 $1.48 Million - $4.6 Million
-54,562 Reduced 49.02%
56,736 $3.99 Million
Q3 2020

Nov 09, 2020
SELL
$28.06 - $37.16 $81,205 - $107,541
-2,894 Reduced 2.53%
111,298 $3.12 Million
Q2 2020

Aug 05, 2020
BUY
$18.5 - $34.34 $1.3 Million - $2.41 Million
70,288 Added 160.09%
114,192 $3.38 Million
Q1 2020

May 06, 2020
BUY
$14.88 - $32.78 $653,291 - $1.44 Million
43,904 New
43,904 $870,000
Q1 2018

May 11, 2018
SELL
$29.84 - $44.08 $3.05 Million - $4.5 Million
-102,075 Closed
0 $0
Q4 2017

Feb 06, 2018
BUY
$21.89 - $31.34 $2.23 Million - $3.2 Million
102,075
102,075 $3.2 Million

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $104M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email